Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cumberland Pharmaceuticals (CPIX) Equity Ratio (2016 - 2026)

Cumberland Pharmaceuticals' Equity Ratio history spans 16 years, with the latest figure at 0.32 for Q4 2025.

  • On a quarterly basis, Equity Ratio rose 5.66% to 0.32 in Q4 2025 year-over-year; TTM through Dec 2025 was 0.32, a 5.66% increase, with the full-year FY2025 number at 0.32, up 5.66% from a year prior.
  • Equity Ratio hit 0.32 in Q4 2025 for Cumberland Pharmaceuticals, down from 0.4 in the prior quarter.
  • Over the last five years, Equity Ratio for CPIX hit a ceiling of 0.54 in Q2 2021 and a floor of 0.3 in Q4 2024.
  • Historically, Equity Ratio has averaged 0.41 across 5 years, with a median of 0.41 in 2023.
  • Biggest five-year swings in Equity Ratio: fell 23.25% in 2022 and later grew 24.32% in 2025.
  • Tracing CPIX's Equity Ratio over 5 years: stood at 0.5 in 2021, then dropped by 23.25% to 0.39 in 2022, then decreased by 7.57% to 0.36 in 2023, then dropped by 15.5% to 0.3 in 2024, then grew by 5.66% to 0.32 in 2025.
  • Business Quant data shows Equity Ratio for CPIX at 0.32 in Q4 2025, 0.4 in Q3 2025, and 0.41 in Q2 2025.